Food supervision

Huawei and Moroccan Government Boost National Education Transformation through DigiSchool Project

AGADIR,Morocco,Dec. 30,2024-- Huawei has announced the successful completion of the DigiSchool 2024 project in Morocco,highlighting its contribution to ensuring equitable access to digital technology

01-03

Wondershare and Dolby Join Forces to Bring Dolby Vision Editing Capability to Filmora Users

VANCOUVER,BC,Dec. 31,2024-- Wondershare Technology,a leader in creative software solutions,has joined hands with Dolby Laboratories to bring the Dolby Vision capability to Wondershare\'s popular vide

01-03

Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEONGNAM,South Korea and BOSTON,Dec. 30,2024-- Bridge Biotherapeutics (KQ288330),a clinical-stage biotech company based inSouth Koreadeveloping novel drugs for fibrosis and cancer,today announced that

01-03

CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel)

SHANGHAI,Dec. 30,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

01-03

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

SEOUL,South Korea,Dec. 31,2024-- CG MedTech (f/k/a Innosys,CEO Ju Mi Chung),a leading Korean orthopedic implant research and manufacturing company,partnered with CGBIO to host the International Spine

01-03

USDA and Cooperators Continued to Lead Discussion and Public Attention to Reduction and Repurposing of Food Waste in Asia at 2nd IFPRUFW in Xiamen, China

XIAMEN,China,Dec. 31,2024--The 2nd International Forum of Prevention,Reduction and Utilization of Food Waste (IFPRUFW) was held in Xiamen Renaissance Hotel in Xiamen,China on Dec. 3-4,2024,to showcase

01-03

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

SHANGHAI,Dec. 31,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

01-03

Pocket Ranger: The Ultimate Choice for Outdoor Adventures and Photography

SHANGHAI,Dec. 31,2024-- Outdoor enthusiasts,eager to capture stunning natural vistas during hikes and climbs,often grapple with a challenge: how to balance gear safety with backpack lightness and comf

01-03

Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers

SAN FRANCISCO,Jan. 2,2025-- Fapon Biopharma,an innovator in developing therapeutic antibodies and fusion proteins,will present its latest breakthrough immunocytokine,FP008,on Jan 14,2025,at the Biote

01-03

FranklinWH Announces General Availability of Whole Home Energy Management System Featuring 15 kWh aPower 2 Battery and 15-Year Warranty

SAN JOSE,Calif.,Jan. 2,2025-- FranklinWH Energy Storage Inc. (FranklinWH),a leader in whole-home energy management,today announced the general availability of its next-generation whole home energy ma

01-03

Home Previous 57 58 59 60 61 62 63 Next Tail

10 Items Per Page (Page 60 / 101) Total 1004 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map